{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:11:38Z","timestamp":1791475898377,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1208\/s12249-014-0257-x","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:02:23Z","timestamp":1418666543000},"page":"704-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effects of the Preparation Method on the Formation of True Nimodipine SBE-\u03b2-CD\/HP-\u03b2-CD Inclusion Complexes and Their Dissolution Rates Enhancement"],"prefix":"10.1208","volume":"16","author":[{"given":"Farouk","family":"Semcheddine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida El Islem","family":"Guissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XueYin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZuoMin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"257_CR1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00003495-198937050-00004","volume":"37","author":"M Langley","year":"1989","unstructured":"Langley M, Sorkin EM. Nimodipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease. Drugs. 1989;37:669\u201399.","journal-title":"Drugs"},{"key":"257_CR2","first-page":"130","volume":"49","author":"W M\u00fcck","year":"1994","unstructured":"M\u00fcck W, Bode H. Bioanalytics of nimodipine\u2014an overview of methods. Pharmazie. 1994;49:130\u20139.","journal-title":"Pharmazie"},{"key":"257_CR3","volume-title":"The extra pharmacopeia (31sted)","author":"JEF Reynolds Martindale","year":"1996","unstructured":"Reynolds Martindale JEF. The extra pharmacopeia (31sted). London: Royal Pharmaceutical Society of Great Britain; 1996."},{"issue":"2","key":"257_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/03639049809085608","volume":"24","author":"J Mielcarek","year":"1998","unstructured":"Mielcarek J. Analytical study of photodegradation of inclusion complexes of nimodipine with alpha-, gamma-cyclodextrin, methyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin. Drug Dev Ind Pharm. 1998;24(2):197\u2013200.","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"257_CR5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jpba.2004.08.024","volume":"36","author":"AV Eeckhant","year":"2004","unstructured":"Eeckhant AV, Robert M, Michotte Y. Separation of neutral dihydropyridines and their enantiomers using electrokinetic chromatography. J Pharmacent Biomed. 2004;36(4):799\u2013805.","journal-title":"J Pharmacent Biomed"},{"issue":"3\u20134","key":"257_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1011155208944","volume":"39","author":"F Kopecky","year":"2001","unstructured":"Kopecky F, Kopecka B, Kaclik P. Solubility study of nimodipine inclusion complexation with alpha- and beta-cyclodextrin and betasome substituted cyclodextrins. J Incl Phenom Macro. 2001;39(3\u20134):215\u20137.","journal-title":"J Incl Phenom Macro"},{"key":"257_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0378-5173(94)00342-3","volume":"118","author":"MA Vandelli","year":"1995","unstructured":"Vandelli MA, Salvioli G, Mucci A, Panini R, Malmusi L, Forni EF. 2-hydroxypropyl-b-cyclodextrin complexation with ursodeoxycholic acid. Int J Pharm. 1995;118:77\u201383.","journal-title":"Int J Pharm"},{"key":"257_CR8","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1248\/cpb.28.3304","volume":"28","author":"K Takayama","year":"1980","unstructured":"Takayama K, Nambu N, Nagai T. Pharmaceutical interactions in dosage forms and processing. XIX. Dissolution kinetics for coprecipitates of indomethacin with polyvinylpyrrolidone. Chem Pharm Bull. 1980;28:3304\u20139.","journal-title":"Chem Pharm Bull"},{"key":"257_CR9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0731-7085(01)00679-3","volume":"28","author":"HA Archontaki","year":"2002","unstructured":"Archontaki HA, Vertzoni MV, Athanassiou-Malaki MH. Study on the inclusion complexes of bromazepam with \u03b2-and \u03b2-hydroxypropyl-cyclodextrins. J Pharm Biomed Anal. 2002;28:761\u20139.","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"257_CR10","first-page":"1","volume":"1","author":"RPM Patel","year":"2010","unstructured":"Patel RPM, Shah D. Application of cyclodextrin in drug delivery. Int J of Pharm Wor Res. 2010;1(2):1\u201321.","journal-title":"Int J of Pharm Wor Res"},{"key":"257_CR11","doi-asserted-by":"crossref","unstructured":"Jain AS, Date AA, [\u2026], Nagarsenker MS. Sulfobutyl Ether7 \u03b2-cyclodextrin (SBE7 \u03b2-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS Pharm Sci Tech. 2011; December; 12 (4):1163\u20131175.","DOI":"10.1208\/s12249-011-9685-z"},{"key":"257_CR12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jps.10359","volume":"92","author":"SF Lockwood","year":"2003","unstructured":"Lockwood SF, O\u2019Malley S, Mosher GL. Improved aqueous solubility of crystalline astaxanthin (3,3\u2032-dihydroxy-\u03b2, \u03b2-carotene-4,4\u2032-dione) by captisol\u00ae (sulfobutyl ether \u03b2-cyclodextrin). J Pharm Sci. 2003;92:922\u20136.","journal-title":"J Pharm Sci"},{"key":"257_CR13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jps.2600840805","volume":"84","author":"RA Rajewski","year":"1995","unstructured":"Rajewski RA, Traiger G, Bresnahan J, Jaberaboansari P, Stella VJ, Thompson DO. Preliminary safety evaluation of parenterally administered sulfoalkyl ether cyclodextrin derivatives. J Pharm Sci. 1995;84:927\u201332.","journal-title":"J Pharm Sci"},{"key":"257_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1023\/A:1016047215907","volume":"13","author":"K Okimoto","year":"1996","unstructured":"Okimoto K, Rajewski RA, Uekama K, Jona JA, Stella VJ. The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins. Pharm Res. 1996;13:256\u201364.","journal-title":"Pharm Res"},{"issue":"2","key":"257_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/03639040801938118","volume":"34","author":"X Zheng","year":"2008","unstructured":"Zheng X, Yang R, Tang X, Zheng L. Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev Ind Pharm. 2008;34(2):232\u20133.","journal-title":"Drug Dev Ind Pharm"},{"key":"257_CR16","unstructured":"Guissi N, Semcheddine F, Wang B. Preparation and characterization of low crystalline and more swollen nimodipine loaded nanostructured lipid carriers and solid lipid nanoparticles in the presence of electrolytes. Int. J. Res. Pharm. Bio. Sci. 2013; 683\u2013691."},{"key":"257_CR17","doi-asserted-by":"crossref","unstructured":"Franti\u0161ek K, Bo\u017eena K, Pavol K. Solubility study of nimodipine inclusion complexation with \u03b1- and \u03b2-cyclodextrin and some substituted cyclodextrins. J Incl Phenom Macro. 2001;39:215\u20137.","DOI":"10.1023\/A:1011155208944"},{"issue":"7","key":"257_CR18","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.21204","volume":"97","author":"X Yang","year":"2008","unstructured":"Yang X, Ke W, Zi P, Liu F, Yu L. Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy. J Pharm Sci. 2008;97(7):2702\u201319.","journal-title":"J Pharm Sci"},{"issue":"1","key":"257_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1248\/cpb.38.176","volume":"38","author":"A Yoshida","year":"1990","unstructured":"Yoshida A, Yamamoto M, Itoh T, Irie T, Hirayama F, Uekama K. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine. Chem Pharm Bull (Tokyo). 1990;38(1):176\u20139.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"257_CR20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5173(98)00390-1","volume":"179","author":"P Mura","year":"1999","unstructured":"Mura P, Faucci MT, Parrini PL, Furlanetto S, Pinzauti S. Influence of the preparation method on the physicochemical properties of ketoprofen-cyclodextrin binary systems. Int J Pharm. 1999;179:117\u201328. doi: 10.1016\/S0378-5173(98)00390-1 .","journal-title":"Int J Pharm"},{"key":"257_CR21","unstructured":"Higuchi T, Connors A. Phase-solubility techniques. In: Advances in analytical chemistry instrumentation. New York, NY: Wiley Interscience; 1965; 117\u2013211."},{"issue":"1","key":"257_CR22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-012-9877-1","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang H et al. Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-\u03b2-cyclodextrin complex for ophthalmic delivery. AAPS Pharm Sci Tech. 2013;14(1):10\u20138.","journal-title":"AAPS Pharm Sci Tech"},{"issue":"4\u20136","key":"257_CR23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cplett.2010.10.046","volume":"500","author":"M Jug","year":"2010","unstructured":"Jug M, Mennini N, Melani F, Maestrelli F, Mura P. Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates. Chem Phys Lett. 2010;500(4\u20136):347\u201354.","journal-title":"Chem Phys Lett"},{"key":"257_CR24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0928-0987(01)00208-1","volume":"15","author":"CM Fernandes","year":"2002","unstructured":"Fernandes CM, Vieira MT, Veiga FJB. Physicochemical characterization and in vitro dissolution behaviour of nicardipine-cyclodextrins inclusion compounds. Eur J Pharm Sci. 2002;15:79\u201388.","journal-title":"Eur J Pharm Sci"},{"key":"257_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"1975","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48\u20139.","journal-title":"J Pharm Pharmacol"},{"key":"257_CR26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2007.07.018","volume":"123","author":"RL Carrier","year":"2007","unstructured":"Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release. 2007;123:78\u201399.","journal-title":"J Control Release"},{"key":"257_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0939-6411(01)00128-X","volume":"51","author":"MO Ahmed","year":"2001","unstructured":"Ahmed MO. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug. Eur J Pharm Biopharm. 2001;51:221\u20136.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"257_CR28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/(SICI)1098-2299(199606)38:2<125::AID-DDR7>3.0.CO;2-L","volume":"38","author":"S De-Chasteign","year":"1996","unstructured":"De-Chasteign S, Fessi H, Davissaguet JP, Puisieusx F. Comparative study of the association of Itraconazole with colloidal drug carrier. Drug Dev Res. 1996;38(2):125\u201333.","journal-title":"Drug Dev Res"},{"issue":"1\u20132","key":"257_CR29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-5173(01)00851-1","volume":"229","author":"Y Nagase","year":"2001","unstructured":"Nagase Y, Hirata M, Wada K, Arima H, Hirayama F, Irie T, et al. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether \u03b2-cyclodextrin. Int J Pharm. 2001;229(1\u20132):163\u201372.","journal-title":"Int J Pharm"},{"issue":"8","key":"257_CR30","doi-asserted-by":"crossref","first-page":"e41072","DOI":"10.1371\/journal.pone.0041072","volume":"7","author":"C Yanez","year":"2012","unstructured":"Yanez C, Canete-Rosales P, Castillo JP, Catalan N, Undabeytia T, Morillo E. Cyclodextrin inclusion complex to improve physicochemical properties of herbicide bentazon: exploring better formulations. PLoS One. 2012;7(8):e41072. doi: 10.1371\/journal.pone.0041072 .","journal-title":"PLoS One"},{"issue":"5","key":"257_CR31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/jps.20325","volume":"94","author":"Y Zheng","year":"2005","unstructured":"Zheng Y, Haworth IS, Zuo Z, Chow MS, Chow AH. Physicochemical and structural characterization of quercetin-b-cyclodextrin complexes. J Pharm Sci. 2005;94(5):1079\u201389.","journal-title":"J Pharm Sci"},{"key":"257_CR32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10847-006-9086-1","volume":"56","author":"YH Zhou","year":"2006","unstructured":"Zhou YH, Zhang GM, Wang ZR, Wang HY, Dong C, MinShuang S. The interaction of piroxicam with neutral (HP-\u03b2-CD) and anionically charged (SBE-\u03b2-CD) \u03b2-cyclodextrin. J Incl Phenom Macro Chem. 2006;56:215\u201320.","journal-title":"J Incl Phenom Macro Chem"},{"key":"257_CR33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.saa.2007.10.004","volume":"70","author":"H Jiang","year":"2008","unstructured":"Jiang H, Li D, Shanshan Y. Synthesis and characterization of \u03b2-cyclodextrin inclusion complex containing di(8-hydroxyquinoline) magnesium. Spectrochim Acta A. 2008;70:878\u201383.","journal-title":"Spectrochim Acta A"},{"issue":"4","key":"257_CR34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1208\/s12249-011-9685-z","volume":"12","author":"AS Jain","year":"2011","unstructured":"Jain AS, Date AA, Pissurlenkar RR, Coutinho EC, Nagarsenker MS. Sulfobutyl Ether7 \u03b2-cyclodextrin (SBE7 \u03b2-CD) carbamazepine complex: Preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS Pharm Sci Tech. 2011;12(4):1163\u201375. doi: 10.1208\/s12249-011-9685-z .","journal-title":"AAPS Pharm Sci Tech"},{"issue":"3","key":"257_CR35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/0250-474X.34559","volume":"69","author":"SN Hiremath","year":"2007","unstructured":"Hiremath SN, Bharti N, Swamy PV, Raju SA. Improved dissolution rate of valdecoxib inclusion complexes with hydroxypropyl-\u03b2-cyclodextrin. Ind J Pharm Sci. 2007;69(3):442\u20135.","journal-title":"Ind J Pharm Sci"},{"issue":"2","key":"257_CR36","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/ijms15021962","volume":"15","author":"C Danciu","year":"2014","unstructured":"Danciu C et al. Genistein in 1:1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation. Int J Mol Sci. 2014;15(2):1962\u201382.","journal-title":"Int J Mol Sci"},{"key":"257_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0928-0987(03)00199-4","volume":"20","author":"LSS Ribeiro","year":"2003","unstructured":"Ribeiro LSS, Ferreira DC, Veiga FJB. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with b cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Eur J Pharm Sci. 2003;20:253\u201366.","journal-title":"Eur J Pharm Sci"},{"key":"257_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-5173(02)00263-6","volume":"243","author":"MA Bayomi","year":"2002","unstructured":"Bayomi MA, Abanumany KA, Al-Angary AA. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Int J Pharm. 2002;243:107\u201317.","journal-title":"Int J Pharm"},{"key":"257_CR39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.01.009","volume":"293","author":"J Manosroi","year":"2005","unstructured":"Manosroi J, Apriyani MG, Foe K, Manosroi A. Enhancement of the release of azaleic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-b-cyclodextrin. Int J Pharm. 2005;293:235\u201340.","journal-title":"Int J Pharm"},{"key":"257_CR40","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3109\/03639049109026630","volume":"17","author":"O Bekers","year":"1991","unstructured":"Bekers O, Uijtendaal EV, Beijnen JH, Bult A, Underberg WJM. Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm. 1991;17:1503\u201349.","journal-title":"Drug Dev Ind Pharm"},{"key":"257_CR41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0939-6411(98)00033-2","volume":"46","author":"RO Williams","year":"1998","unstructured":"Williams RO, Mahaguna V, Sriwongjanya M. Characterization of an inclusion complex of cholesterol and hydroxypropyl-b-cyclodextrin. Eur J Pharm Biopharm. 1998;46:355\u201360.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20134","key":"257_CR42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10847-012-0268-8","volume":"77","author":"DK Batt","year":"2013","unstructured":"Batt DK, Garala KC. Preparation and evaluation of inclusion complexes of diacerein with \u03b2-cyclodextrin and hydroxypropyl \u03b2-cyclodextrin. J Incl Phenom Macrocycl Chem. 2013;77(1\u20134):471\u201381.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"257_CR43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0928-0987(02)00107-0","volume":"16","author":"E Spamer","year":"2002","unstructured":"Spamer E, Mullera DG, Wessels PL, Venter JP. Characterization of the complexes of furosemide with 2-hydroxypropyl-b-cyclodextrin and sulfobutyl ether-7-b-cyclodextrin. Eur J Pharm Sci. 2002;16:247\u201353.","journal-title":"Eur J Pharm Sci"},{"key":"257_CR44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10847-012-0110-3","volume":"75","author":"C Cannav\u00e0","year":"2013","unstructured":"Cannav\u00e0 C, Crupi V, Guardo M, Majolino D, Stancanelli R, Tommasini S, et al. Phase-solubility and FTIR-ATR studies of idebenone\/sulfobutyl ether beta-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem. 2013;75:255\u201366.","journal-title":"J Incl Phenom Macrocycl Chem"},{"key":"257_CR45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.vibspec.2003.09.002","volume":"33","author":"I Garc\u00eda-Zubiri","year":"2003","unstructured":"Garc\u00eda-Zubiri I, Gonz\u00e1lez-Gaitano G, S\u00e1nchez M, Isasi JR. FTIR study of dibenzofuran-2-carboxylic acid and its complexes with \u03b2-cyclodextrin. Vib Spectrosc. 2003;33:205\u201313.","journal-title":"Vib Spectrosc"},{"key":"257_CR46","doi-asserted-by":"crossref","unstructured":"Zaibunnisa et al. Characterization of cyclodextrin complexes with turmeric oleoresin. Food Chemistry 114 (2009) 459\u2013465.","DOI":"10.1016\/j.foodchem.2008.09.072"},{"key":"257_CR47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0045-6535(96)00175-0","volume":"33","author":"JM Gines","year":"1996","unstructured":"Gines JM, P\u00e9rez-Mart\u00ednez JI, Arias MJ, Moyano JR, Morillo E, Ruiz-Conde A, et al. Inclusion of the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) with beta- cyclodextrin by different processing methods. Chemosphere. 1996;33:321\u201334.","journal-title":"Chemosphere"},{"key":"257_CR48","doi-asserted-by":"crossref","unstructured":"Bongiorno D. et al. Inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin in solid phase. ARKIVOC 2005 (xiv) 118\u2013130.","DOI":"10.3998\/ark.5550190.0006.e14"},{"key":"257_CR49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.2042-7158.1982.tb04689.x","volume":"34","author":"OI Corrigan","year":"1982","unstructured":"Corrigan OI, Stanley CT. Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems. J Pharm Pharmacol. 1982;34:621\u20136.","journal-title":"J Pharm Pharmacol"},{"key":"257_CR50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/js990067o","volume":"88","author":"G Dollo","year":"1999","unstructured":"Dollo G, Corre P, Chollet M, Chevanne F, Bertault M, Burgot J, et al. Improvement in solubility and dissolution rate of 1,2-dithiole-3-thiones upon complexation with b-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J Pharm Sci. 1999;88:889\u201395.","journal-title":"J Pharm Sci"},{"key":"257_CR51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0250-474X.36939","volume":"69","author":"S Rawat","year":"2007","unstructured":"Rawat S, Jain SK. Enhancement of intestinal absorption of few COX-2 inhibitors through interaction with \u03b2-cyclodextrin. Ind J Pharm Sci. 2007;69:529\u201334.","journal-title":"Ind J Pharm Sci"},{"issue":"1","key":"257_CR52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/s12249-008-9180-3","volume":"10","author":"S Sathigari","year":"2009","unstructured":"Sathigari S et al. Physicochemical characterization of Efavirenz\u2013cyclodextrin inclusion complexes. AAPS PharmSciTech. 2009;10(1):81\u20137.","journal-title":"AAPS PharmSciTech"},{"key":"257_CR53","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/js990067o","volume":"88","author":"G Dollo","year":"1999","unstructured":"Dollo G, Corre P, Chollet M, Chevanne F, Bertault M, Burgot JL, et al. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. J Pharm Sci. 1999;88:889\u201395. doi: 10.1021\/js990067o .","journal-title":"J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0257-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-014-0257-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-014-0257-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T09:18:43Z","timestamp":1566119923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-014-0257-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1208\/s12249-014-0257-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}